NCT05174572Completed
IMR Evaluation in Patients with Coronary Sinus Reducer Implantation (INROAD Study)
Index of Microcirculatory Resistance Evaluation in Patients with Coronary Sinus Reducer Implantation for the Treatment of Chronic Refractory Angina Pectoris, the INROAD Study
Source: ClinicalTrials.gov · Last updated 13 Feb 2025
Brief summary (registry, in English)
The INROAD is an investigator-driven, prospective, study in which patients undergoing coronary sinus reducer implantation (Reducer) for chronic refractory angina undergo evaluation of the index of microcirculatory resistance (IMR) at the time of implantation, and at 4 months follow-up
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 21 (actual)
- First submitted
- 3 Dec 2021
- Start date
- 3 Dec 2021
- Primary completion date
- 31 Mar 2023
- Lead sponsor
- Consorzio Futuro in Ricerca
- Diseases
- Coronary artery disease
- NCT number
- NCT05174572
What you commit to
- Study type: Interventional
- Participants enrolled: 21
- From 3 Dec 2021 to the primary completion date, 31 Mar 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Technical contraindications to the implant ( A pacemaker electrode in the coronary sinus, Mean right atrial pressure \>15mmHg, Anomalous coronary sinus anatomy)
Other illness
- Recent (within 3 months) acute coronary syndrome
- Severe valvular heart disease
Lab values
- Left ventricular ejection fraction of \<30%
Other
- Inability to perform IMR
Who the study is looking for
- Age ≥ 18 years old
- Chronic refractory angina refractory to medical and interventional therapies.
- At least one open coronary artery (excluded right coronary artery) where to performs IMR evaluation
- Ability to provide informed written consent
- Life expectancy ≥1 year
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Azienda Ospedaliero Universitaria di Ferrara Coordinator of this site? Confirm its status | Ferrara | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.